@FierceBiotech: Struggling Capstone delays key data analysis on lead drug. News | Follow @FierceBiotech
@JohnCFierce: One thing XenoPort's CEO Ron Barrett told me: Talk to the FDA as much as you can during development. It might help you avoid a serious delay. | Follow @JohnCFierce
> After threatening to close three R&D sites in the Netherlands, laying off a thousand workers, Merck now says it will keep 486 workers. The move follows protests over the planned shutdown. Report
> Valeant CEO J. Michael Pearson has won over investors with his appetite for acquisitions and a reputation for slashing R&D. "R&D is a very risky investment," Pearson tells Bloomberg. "The odds of you succeeding in that are kind of against you." Story
> The FDA says that it has taken several steps to safeguard data at the agency after a chemist was accused of using insider information to reap a multimillion-dollar windfall on biotech stock trades. Story
> Concerned by an FDA advisory panel's split vote on a key claim for the newly approved antibiotic fidaxomicin, investors trimmed seven percent off its share price on Wednesday. Report
Pharma News
@FiercePharma: Rejected Valeant aims to replace Cephalon board. Story | Follow @FiercePharma
> Some pharma products scarce in disaster-damaged Japan. Story
> Novartis sells off skin treatment for $420M. News
> Analyst: J&J may need a $10B-plus deal. Report
> GSK among final bidders for Turkey's Biofarma. Article
> Valeant bid re-focuses pharma M&A interest. Item
> Merck loses fight for Gardasil use in older women. Story
Vaccines News
> Nuron buys Hib vaccine from Wyeth, plots relaunch. Story
> Biovest sees new opportunities following bankruptcy. Article
> Dana-Farber finds new AIDS vax target. Report
> Intercell and Novartis collaborate on Pseudomonas vax. Item
Manufacturing News
> Canine recruited in counterfeits fight. News
> Draft gives non-penicillin ops guidance. Article
> Sweet deal keeps Bayer in NJ. Item
> DHL teams for frozen shipments. Report
> HealthSport buys SMI assets. Story
> Ningbo warning letter in line with FDA agenda. Article
And Finally... The lethal NDM 1-positive bacteria, a superbug known for its resistance to drugs, has been found in New Delhi's water supply. Story